Access
Login/Register
Supplier Login
To support the rapidly growing market for probiotics, Chr. Hansen has invested in the construction of a freeze-drying plant for pharmaceutical-grade cultures. The facility, located in Roskilde, south of Copenhagen, Denmark, has a layout where visitors can observe and inspect the main operations and equipment during production. It is designed to improve working conditions. With 1:1 models of different work stations, the design passed occupational health and safety standards before the construction work was started. It will be completed by 2014.
Probiotics for dietary supplements
Based on new industry analysis, the global probiotics market is forecast to surge by 6.8% a year until 2018, driven by Asia-Pacific, and with Europe as another dominant market in spite of current health claim law issues1. In sales terms this corresponds to US$27.9 billion in 2011, forecast to reach $44.9 billion in 2018.
The increasing culture sales, both in terms of probiotics and food cultures, puts pressure on Chr. Hansen’s production facilities and in order to sustain the growing customer demand the global bioscience company is investing in expanding its capacity.
Freeing production capacity for other culture types
“Over the past years we have worked to turn our production facility at Roskilde south of Copenhagen into a dedicated production site for human health products, both to live up to pharma GMPs and to free capacity at our food culture production site in Copenhagen,” says Henrik Dalboege, executive vice president, Human Health & Nutrition Division, Chr. Hansen.
“We started the construction work on the new freeze-drying plant just beKobe 13 A.D. Shoes